world
Study Links GLP-1 Drugs to Reduced Impulsivity
A new study suggests GLP-1 medications may affect decision-making beyond appetite control. Research examined links between these drugs and behavior in people taking them.
Jun 17, 7:41 AM·1m read1 source
nypost.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A new study suggests GLP-1 medications such as Ozempic and Mounjaro may influence choices beyond food intake.
The medications are primarily prescribed for type 2 diabetes and weight management. Researchers reported associations between GLP-1 use and reduced impulsivity in some participants.
Further research is needed to determine whether these effects translate into measurable changes in behavior outside laboratory settings.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
